NDC 51144-003 – Tivdak

Tisotumab Vedotin 40 mg/4mL · Injection, Powder, For Solution · Intravenous

Human Prescription Drug

Product NDC51144-003

Product details

Brand name
Tivdak
Generic name
Tisotumab vedotin
Labeler
SEAGEN INC.
Dosage form
Injection, Powder, For Solution
Route
Intravenous
Marketing category
BLA · BLA761208
Marketed since
September 20, 2021
Listing expires
December 31, 2026

Active ingredients

Uses, dosage, side effects and warnings for Tivdak →

Package NDC codes (1)

Package NDCDescriptionSince
51144-003-011 VIAL in 1 CARTON (51144-003-01) / 4 mL in 1 VIALSep 20, 2021